BioPower Operations Corporation
BOPO · OTC
5/31/2023 | 2/28/2023 | 11/30/2022 | 8/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $125 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $125 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $249 | $432 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,446 | $51 | $396 | $403 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$432 | $0 | $0 |
| Operating Expenses | $4,695 | $51 | $396 | $403 |
| Operating Income | -$4,695 | -$51 | -$396 | -$278 |
| % Margin | – | – | – | -222.8% |
| Other Income/Exp. Net | -$62 | -$146 | -$141 | $35 |
| Pre-Tax Income | -$4,757 | -$148 | -$537 | -$244 |
| Tax Expense | $0 | $172 | $0 | $0 |
| Net Income | -$4,757 | -$320 | -$541 | -$174 |
| % Margin | – | – | – | -139.3% |
| EPS | -0.1 | -0.007 | -0.012 | -0.004 |
| % Growth | -1,328.6% | 41.2% | -213.2% | – |
| EPS Diluted | -0.1 | -0.007 | -0.012 | -0.004 |
| Weighted Avg Shares Out | 45,868 | 45,625 | 45,302 | 45,598 |
| Weighted Avg Shares Out Dil | 45,868 | 45,625 | 45,302 | 45,598 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $45 | $97 | $137 | $35 |
| Depreciation & Amortization | $4,229 | $483 | $396 | $278 |
| EBITDA | -$483 | -$51 | -$4 | $0 |
| % Margin | – | – | – | 0% |